Hanzawa, Kyoko <br/><br/>
Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era.  [electronic resource] 

 -  Leukemia & lymphoma  Nov 2010 
 - 2054-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2010.522285  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Pharmacological--metabolism<br/>Biomarkers, Tumor--metabolism<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Female<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--diagnosis<br/>Male<br/>Middle Aged<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Rituximab<br/>Survival Analysis<br/>Vincristine--therapeutic use<br/>Y-Box-Binding Protein 1--metabolism